肠内餵食配方市场－全球产业规模、份额、趋势、机会和预测，按产品、流程类型、阶段、适应症、最终用途、地区和竞争细分，2020-2030 年

2024 年全球肠内餵食配方市场价值为 67.5 亿美元，预计在预测期内将稳定成长，到 2030 年的复合年增长率为 6.75%。全球医疗保健产业正在经历范式转变，越来越关注整体病患照护。患者健康的关键方面是营养，对于因医疗条件而无法口服食物的人来说，肠内餵食配方已成为至关重要的解决方案。

全球肠内餵食配方市场在确保从早产儿到老年患者的个人获得康復和整体健康所需的必需营养素方面发挥着关键作用。肠内餵食涉及透过管子将营养物质直接输送到胃肠道。当个人因吞嚥障碍、消化问题或重症等情况而无法口服食物时，就会采用这种方法。肠内餵食配方，也称为肠内营养或管饲配方，是含有均衡混合的常量营养素、维生素和矿物质的专门液体溶液。这些配方旨在满足从婴儿到成人的不同患者群体的特定营养需求。它们可分为多种类型，包括标准配方、特定疾病配方以及针对糖尿病或肾衰竭等特定医疗状况的专门配方。世界上的老龄人口容易出现一系列健康问题，影响他们的正常饮食能力。这导致针对老年人营养需求的肠内餵食配方的需求增加。

关键市场驱动因素

慢性病盛行率上升

主要市场挑战

监管障碍和

主要市场趋势

技术进步

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：肠内餵食配方市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 副产品（标准配方、特定疾病配方）
  • 依流量类型（间歇供料流量、连续供料流量）
  • 依分期（成人、儿科）
  • 依适应症（阿兹海默症、营养不良、癌症照护、糖尿病、慢性肾臟病、孤儿病、吞嚥困难、疼痛管理、吸收不良/胃肠道疾病/腹泻、其他）
  • 依最终用途（医院、家庭护理）
  • 按地区
  • 按公司分类（2024）
• 市场地图

第六章：北美肠内餵食配方市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲肠内餵食配方市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 德国
  • 英国
  • 义大利
  • 法国
  • 西班牙

第八章：亚太肠内餵食配方市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：南美肠内餵食配方市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东和非洲肠内餵食配方市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 最新动态
• 产品发布
• 併购

第 13 章：全球肠内餵食配方市场：SWOT 分析

第 14 章：竞争格局

• Abbott Laboratories Inc
• Danone SA
• Fresenius Kabi AG
• Nestle SA
• VICTUS Inc.
• Primus Pharmaceuticals, Inc.
• Meiji Holdings. Co Ltd.
• Mead Johnson & Company, LLC

第 15 章：策略建议

第16章调查会社について・免责事项

Global Enteral Feeding Formulas Market was valued at USD 6.75 Billion in 2024 and is anticipated to project steady growth in the forecast period with a CAGR of 6.75% through 2030. The global healthcare industry is undergoing a paradigm shift, with a growing focus on holistic patient care. One essential aspect of patient well-being is nutrition, and for individuals who cannot consume food orally due to medical conditions, enteral feeding formulas have emerged as a crucial solution.

The Global Enteral Feeding Formulas Market plays a pivotal role in ensuring that individuals, ranging from premature infants to elderly patients, receive the essential nutrients they need for recovery and overall health. Enteral feeding involves providing nutrients directly into the gastrointestinal tract via a tube. This method is employed when individuals are unable to consume food orally due to conditions such as swallowing disorders, digestive issues, or critical illness. Enteral feeding formulas, also known as enteral nutrition or tube feeding formulas, are specialized liquid solutions containing a balanced mix of macronutrients, vitamins, and minerals. These formulas are designed to match the specific nutritional needs of different patient groups, ranging from infants to adults. They can be categorized into various types, including standard formulas, disease-specific formulas, and specialized formulations for specific medical conditions like diabetes or renal failure. The world's aging population is prone to a range of health conditions that can affect their ability to eat normally. This has led to an increased demand for enteral feeding formulas tailored to the nutritional needs of the elderly.

Key Market Drivers

Rising Prevalence of Chronic Diseases

The global enteral feeding formulas market is witnessing substantial growth, primarily driven by the increasing prevalence of chronic diseases. In 2021, cardiovascular diseases remained the leading cause of mortality among non-communicable diseases (NCDs), accounting for at least 19 million deaths. Cancer followed closely, responsible for 10 million fatalities, while chronic respiratory diseases and diabetes contributed to 4 million and over 2 million deaths, respectively including kidney disease deaths linked to diabetes. Collectively, these four disease categories were responsible for 80% of all premature NCD-related deaths, underscoring their significant impact on global healthcare systems and the urgent need for targeted medical and nutritional interventions. As the global burden of conditions such as cancer, neurological disorders, diabetes, and gastrointestinal diseases continues to rise, the demand for enteral nutrition as a critical component of patient care is expanding. In 2020, cancer was a major global health burden, causing nearly 10 million deaths-equivalent to approximately one in every six fatalities worldwide. Chronic diseases often lead to conditions that impair normal eating and digestion, necessitating the use of enteral feeding formulas to ensure proper nutrient intake. For instance, cancer patients undergoing chemotherapy frequently experience severe appetite loss and gastrointestinal complications, making enteral nutrition essential for maintaining strength and immune function. Similarly, neurological disorders such as Parkinson's disease, multiple sclerosis, and stroke often cause dysphagia (difficulty swallowing), further driving demand for liquid-based nutritional support.

Key Market Challenges

Regulatory Hurdles and

One of the primary challenges confronting the enteral feeding formulas market is the complex regulatory landscape. Different countries have varying regulations and standards governing the production, labeling, and marketing of these products. Manufacturers must navigate a maze of regulations to ensure their products comply with local laws while also meeting global quality standards. This not only increases operational complexity but also poses a barrier for new entrants looking to establish themselves in the market.

Key Market Trends

Technological Advancements

Technological advancements in the field of enteral feeding formulas have touched various aspects of the market, revolutionizing both product development and administration methods. Technological innovations have enabled the development of highly specialized and nutritionally advanced enteral feeding formulas. These formulas are designed to cater to the specific nutritional requirements of patients with varying medical conditions, such as diabetes, renal failure, and gastrointestinal disorders. Through precise formulation and the inclusion of bioactive ingredients, these advanced formulas contribute to better patient recovery and improved overall health. Incorporation of cutting-edge delivery systems has revolutionized how enteral nutrition is administered. The development of pumps with programmable features has allowed for the precise delivery of enteral feeding formulas, ensuring that patients receive the required nutrients at the right rate and consistency. Such devices also minimize the risk of overfeeding or underfeeding, reducing potential complications. The integration of Internet of Things (IoT) technology has led to the creation of smart feeding pumps and monitoring devices. These devices can transmit real-time data about patients' nutritional intake, tube placement, and feeding progress to healthcare professionals.

Key Market Players

• Abbott Laboratories Inc
• Danone S.A
• Fresenius Kabi AG
• Nestle S.A.
• VICTUS Inc.
  • Primus Pharmaceuticals, Inc.
• Meiji Holdings. Co Ltd.
• Mead Johnson & Company, LLC

Report Scope:

In this report, the Global Enteral Feeding Formulas Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Enteral Feeding Formulas Market, By Product:

• Standard Formula
• Disease-specific Formulas

Enteral Feeding Formulas Market, By Flow Type:

• Intermittent Feeding Flow
• Continuous Feeding Flow

Enteral Feeding Formulas Market, By Stage:

• Adults
• Pediatrics

Enteral Feeding Formulas Market, By Indication:

• Alzheimer's
• Nutrition Deficiency
• Cancer Care
• Diabetes
• Chronic Kidney Diseases
• Orphan Diseases
• Dysphagia
• Pain Management
• Malabsorption/GI Disorder/Diarrhea
• Others

Enteral Feeding Formulas Market, By End User:

• Hospitals
• Homecare

Enteral Feeding Formulas Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Enteral Feeding Formulas Market.

Available Customizations:

Global Enteral Feeding Formulas Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Enteral Feeding Formulas Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Standard Formula, Disease-specific Formulas)
  • 5.2.2. By Flow Type (Intermittent Feeding Flow, Continuous Feeding Flow)
  • 5.2.3. By Stage (Adults, Pediatrics)
  • 5.2.4. By Indication (Alzheimer's, Nutrition Deficiency, Cancer Care, Diabetes, Chronic Kidney Diseases, Orphan Diseases, Dysphagia, Pain Management, Malabsorption/GI Disorder/Diarrhea, Others)
  • 5.2.5. By End-Use (Hospitals, Homecare)
  • 5.2.6. By Region
  • 5.2.7. By Company (2024)
• 5.3. Market Map

6. North America Enteral Feeding Formulas Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Flow Type
  • 6.2.3. By Stage
  • 6.2.4. By Indication
  • 6.2.5. By End User
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Enteral Feeding Formulas Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Flow Type
      • 6.3.1.2.3. By Stage
      • 6.3.1.2.4. By Indication
      • 6.3.1.2.5. By End User
  • 6.3.2. Canada Enteral Feeding Formulas Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Flow Type
      • 6.3.2.2.3. By Stage
      • 6.3.2.2.4. By Indication
      • 6.3.2.2.5. By End User
  • 6.3.3. Mexico Enteral Feeding Formulas Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Flow Type
      • 6.3.3.2.3. By Stage
      • 6.3.3.2.4. By Indication
      • 6.3.3.2.5. By End User

7. Europe Enteral Feeding Formulas Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Flow Type
  • 7.2.3. By Stage
  • 7.2.4. By Indication
  • 7.2.5. By End User
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Enteral Feeding Formulas Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Flow Type
      • 7.3.1.2.3. By Stage
      • 7.3.1.2.4. By Indication
      • 7.3.1.2.5. By End User
  • 7.3.2. United Kingdom Enteral Feeding Formulas Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Flow Type
      • 7.3.2.2.3. By Stage
      • 7.3.2.2.4. By Indication
      • 7.3.2.2.5. By End User
  • 7.3.3. Italy Enteral Feeding Formulas Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Flow Type
      • 7.3.3.2.3. By Stage
      • 7.3.3.2.4. By Indication
      • 7.3.3.2.5. By End User
  • 7.3.4. France Enteral Feeding Formulas Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Flow Type
      • 7.3.4.2.3. By Stage
      • 7.3.4.2.4. By Indication
      • 7.3.4.2.5. By End User
  • 7.3.5. Spain Enteral Feeding Formulas Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Flow Type
      • 7.3.5.2.3. By Stage
      • 7.3.5.2.4. By Indication
      • 7.3.5.2.5. By End User

8. Asia-Pacific Enteral Feeding Formulas Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Flow Type
  • 8.2.3. By Stage
  • 8.2.4. By Indication
  • 8.2.5. By End User
  • 8.2.6. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Enteral Feeding Formulas Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Flow Type
      • 8.3.1.2.3. By Stage
      • 8.3.1.2.4. By Indication
      • 8.3.1.2.5. By End User
  • 8.3.2. India Enteral Feeding Formulas Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Flow Type
      • 8.3.2.2.3. By Stage
      • 8.3.2.2.4. By Indication
      • 8.3.2.2.5. By End User
  • 8.3.3. Japan Enteral Feeding Formulas Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Flow Type
      • 8.3.3.2.3. By Stage
      • 8.3.3.2.4. By Indication
      • 8.3.3.2.5. By End User
  • 8.3.4. South Korea Enteral Feeding Formulas Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Flow Type
      • 8.3.4.2.3. By Stage
      • 8.3.4.2.4. By Indication
      • 8.3.4.2.5. By End User
  • 8.3.5. Australia Enteral Feeding Formulas Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Flow Type
      • 8.3.5.2.3. By Stage
      • 8.3.5.2.4. By Indication
      • 8.3.5.2.5. By End User

9. South America Enteral Feeding Formulas Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Flow Type
  • 9.2.3. By Stage
  • 9.2.4. By Indication
  • 9.2.5. By End User
  • 9.2.6. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Enteral Feeding Formulas Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Flow Type
      • 9.3.1.2.3. By Stage
      • 9.3.1.2.4. By Indication
      • 9.3.1.2.5. By End User
  • 9.3.2. Argentina Enteral Feeding Formulas Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Flow Type
      • 9.3.2.2.3. By Stage
      • 9.3.2.2.4. By Indication
      • 9.3.2.2.5. By End User
  • 9.3.3. Colombia Enteral Feeding Formulas Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Flow Type
      • 9.3.3.2.3. By Stage
      • 9.3.3.2.4. By Indication
      • 9.3.3.2.5. By End User

10. Middle East and Africa Enteral Feeding Formulas Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Flow Type
  • 10.2.3. By Stage
  • 10.2.4. By Indication
  • 10.2.5. By End User
  • 10.2.6. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Enteral Feeding Formulas Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Flow Type
      • 10.3.1.2.3. By Stage
      • 10.3.1.2.4. By Indication
      • 10.3.1.2.5. By End User
  • 10.3.2. Saudi Arabia Enteral Feeding Formulas Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Flow Type
      • 10.3.2.2.3. By Stage
      • 10.3.2.2.4. By Indication
      • 10.3.2.2.5. By End User
  • 10.3.3. UAE Enteral Feeding Formulas Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Flow Type
      • 10.3.3.2.3. By Stage
      • 10.3.3.2.4. By Indication
      • 10.3.3.2.5. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Enteral Feeding Formulas Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Abbott Laboratories Inc
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Danone S.A
• 14.3. Fresenius Kabi AG
• 14.4. Nestle S.A.
• 14.5. VICTUS Inc.
• 14.6. Primus Pharmaceuticals, Inc.
• 14.7. Meiji Holdings. Co Ltd.
• 14.8. Mead Johnson & Company, LLC

15. Strategic Recommendations

16. About Us & Disclaimer